These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7690928)

  • 1. Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620+ p53 conformation.
    Medcalf EA; Milner J
    Oncogene; 1993 Oct; 8(10):2847-51. PubMed ID: 7690928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.
    Nakagawa S; Watanabe S; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    Virology; 1995 Oct; 212(2):535-42. PubMed ID: 7571423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6.
    Molinari M; Milner J
    Oncogene; 1995 May; 10(9):1849-54. PubMed ID: 7753560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6.
    Crook T; Ludwig RL; Marston NJ; Willkomm D; Vousden KH
    Virology; 1996 Mar; 217(1):285-92. PubMed ID: 8599213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
    Mansur CP; Marcus B; Dalal S; Androphy EJ
    Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53.
    Stewart D; Ghosh A; Matlashewski G
    J Virol; 2005 Jul; 79(14):8773-83. PubMed ID: 15994771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
    Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53.
    Giovane C; Trave G; Briones A; Lutz Y; Wasylyk B; Weiss E
    J Mol Recognit; 1999; 12(2):141-52. PubMed ID: 10398405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
    Mantovani F; Banks L
    Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
    Thomas M; Matlashewski G; Pim D; Banks L
    Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoexpression of mutant p53 and human papillomavirus related E6 oncoprotein in anal malignancies.
    Gupta S; Sharma BK
    Indian J Exp Biol; 1998 Sep; 36(9):875-8. PubMed ID: 9854426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.
    Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R
    Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of TP53 in Cervical carcinogenesis.
    Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
    Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
    Hampson L; Kitchener HC; Hampson IN
    Antivir Ther; 2006; 11(6):813-25. PubMed ID: 17310826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53.
    Vousden KH; Vojtesek B; Fisher C; Lane D
    Oncogene; 1993 Jun; 8(6):1697-702. PubMed ID: 8389035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
    García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
    Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation.
    Sherman L; Jackman A; Itzhaki H; Stöppler MC; Koval D; Schlegel R
    Virology; 1997 Oct; 237(2):296-306. PubMed ID: 9356341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer.
    Agarwal SK; Chatterji A; Bhambhani S; Sharma BK
    Indian J Exp Biol; 1998 Jun; 36(6):559-63. PubMed ID: 9731468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.